Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

Glox Therapeutics has appointed of Michael Murray as chair of its board. He will work with the leadership team to accelerate ...

PATIENTS taking blockbuster diabetes and weight loss drugs are waking up with vision loss, researchers warn. Some reported ...

Class A shares underperformed the MSCI ACWI ex USA Index. During the quarter, we initiated four new positions and exited one ...

Health experts are investigating a possible link between popular weight loss drugs like Ozempic and sudden blindness.

The mining company that owns the licence to Greenland's Kvanefjeld deposit is hopeful that a new government will repeal a ban ...

Experts from five states have sounded the alarm about blockbuster weight loss drugs like Ozempic leaving users blind, ...

A screenshot of an X post shared on Instagram claims Denmark is purportedly planning to charge Americans a 500% tariff on Ozempic. Verdict: False According to USA Today, the claim stems from LinkedIn ...

Norsk Folkehjelp (Norwegian People’s Aid), one of Europe’s largest humanitarian organizations, has been forced to lay off 1,700 employees out of 3,200 due to the aid freeze imposed by the United ...

Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on naturally occurring ...

In 2024, the Association for Eating Disorders and Self-Harm reported a 22% increase in support requests, with a record 6,754 conversations held across phone, chat, SMS, and in-person consultations.

Exane analyst Victor Floch upgraded Genmab (NASDAQ:GMAB) A/S shares from Underperform to Neutral, adjusting the price target ...